History
Documents created during the development process.
Draft guidance
Committee meetings
-
Committee meeting
-
-
-
-
Agenda : Pfizer submission - Global Atlas Surveillance data 2014-2020 (MSWord 17 KB)
-
Agenda : Pfizer submission - Paper reference table (MSWord 21 KB)
-
Agenda : Patient group submission - Anthony Nolan (MSWord 66 KB)
-
Agenda : Patient group submission - Antibiotic Research UK (MSWord 70 KB)
-
Agenda : Professional group submission - British Infection Association (MSWord 62 KB)
-
-
Agenda : Professional group submission - Intensive Care Society (MSWord 72 KB)
-
Agenda : Professional group submission - UK Cystic Fibrosis Medical Association (MSWord 64 KB)
-
-
Agenda : Clinical expert Andrew Seaton - statement (MSWord 69 KB)
-
Agenda : Clinical expert Andrew Seaton - additional information (MSWord 70 KB)
-
Agenda : Clinical expert Nick Brown - statement (MSWord 70 KB)
-
Agenda : Clinical expert Marisa Lanzman - statement (MSWord 61 KB)
-
Agenda : Patient expert Nicola Andrews - statement (MSWord 63 KB)
-
Agenda : NHS commissioning expert - statement (MSWord 59 KB)
-
Agenda : Assessment report prepared by EEPRU (MSWord 5.61 MB)
-
Agenda : Comments on the assessment report Pfizer from (MSWord 838 KB)
-
Agenda : Comments on the assessment report from clinical expert - Andrew Seaton (MSWord 34 KB)
-
Agenda : Comments on the assessment report from Antibiotic Research UK (MSWord 344 KB)
-
Agenda : Comments on the assessment report from British Infection Association (MSWord 36 KB)
-
-
Agenda : Comments on the assessment report from Intensive Care Society (MSWord 34 KB)
-
Agenda : Comments on the assessment report from NHS England-NHS Improvement (MSWord 35 KB)
-
Agenda : Comments on the assessment report from Merck Sharp & Dohme (MSWord 37 KB)
-
Agenda : Comments on the assessment report from Shionogi (MSWord 263 KB)
-
-
-
-
-
-
-